Showing results (451-460 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|May 13, 2019
Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese VolunteersNan Zhao, Ran Xie, Xia Zhao, et al.Clinical Drug Investigation|September 17, 2018
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug UtilizationHsiang-Yin Chen, Pei-Yin Chiu, Ching-Jun Chang, et al.Clinical Drug Investigation|September 17, 2018
Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without GoutTatsuo Hosoya, Tomohiko Ishikawa, Yoshimi Ogawa, et al.Clinical Drug Investigation|September 21, 2018
Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese SubjectsChaoying Hu, Xiao Hu, Chunhua Wang, et al.Clinical Drug Investigation|June 29, 2019
Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case ReportJanet PanClinical Drug Investigation|October 11, 2019
Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple SclerosisAngela Aungst, Lise Casady, Crystal Dixon, et al.Clinical Drug Investigation|July 4, 2019
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet TherapyKouhei Nii, Yusuke Morinaga, Takafumi Mitsutake, et al.Clinical Drug Investigation|August 10, 2012
Current status of hepatocellular carcinoma treatment in Japan: practical use of sorafenib (Nexavar®)Norihiro Kokudo, Junta Nakajima, Etsuro Hatano, et al.Clinical Drug Investigation|August 11, 2012
Intravenous busulfan: a guide to its use as conditioning treatment before transplantation of haematopoietic progenitor cellsLesley J Scott, Sheridan M Hoy, Katherine A Lyseng-WilliamsonClinical Drug Investigation|April 25, 2023
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control StudyHaiyi Deng, Jiating Deng, Xinqing Lin, et al.Pageof 233